Kyowa Kirin

POTELIGEO

Manufacturer:

Kyowa Kirin

Poteligeo HCPCS:

J9204

HCPCS Code Descriptor:

Injection, mogamulizumab-kpkc, 1 mg

Category:

J Code

Poteligeo NDCs:

42747-0761-01

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Poteligeo:

POTELIGEO is an Oncology drug manufactured by Kyowa Kirin and administered via the Intravenous route of administration. The J Code: J9204 is aligned to the drug POTELIGEO.

ACCESS PRICING AND MORE BY REGISTERING

J9204 Added Date:

October 1, 2019

J9204 Effective Date:

October 1, 2019

J9204 Termination Date:

HCPCS Active

Poteligeo billing and coding information can be found through Kyowa Kirin at the link below:
Poteligeo patient assistance information can be found through Kyowa Kirin Cares at the URL: https://www.kyowakirincares.com/poteligeo-patients/
POTELIGEO prescribing information can be found at the link below:
Information regarding POTELIGEO’s side effects can be found at MedlinePlus